Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 13
2005 2
2007 1
2008 1
2010 2
2011 2
2012 3
2014 1
2015 1
2016 1
2018 1
2019 1
2020 3
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
[Anal HPV infections].
Aigner F, Conrad F, Widschwendter A, Zangerle R, Zelger B, Haidenberger A, Roka S, Heim K, Höpfl R, Klimpfinger M, Rigler YM, Bonatti H, Pfeifer J, Maier A, Kirnbauer R, Salat A. Aigner F, et al. Among authors: widschwendter a. Wien Klin Wochenschr. 2008;120(19-20):631-41. doi: 10.1007/s00508-008-1059-5. Wien Klin Wochenschr. 2008. PMID: 19083168 German. No abstract available.
Recurrence of genitals warts in pre-HPV vaccine era after laser treatment.
Widschwendter A, Böttcher B, Riedl D, Coban S, Mutz-Dehbalaie I, Matteucci Gothe R, Ciresa-König A, Marth C, Fessler S. Widschwendter A, et al. Arch Gynecol Obstet. 2019 Sep;300(3):661-668. doi: 10.1007/s00404-019-05242-5. Epub 2019 Jul 8. Arch Gynecol Obstet. 2019. PMID: 31286210 Free PMC article.
Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
Polterauer S, Reich O, Widschwendter A, Hadjari L, Bogner G, Reinthaller A, Joura E, Trutnovsky G, Ciresa-Koenig A, Ganhoer-Schimboeck J, Boehm I, Berger R, Langthaler E, Aberle SW, Heinze G, Gleiss A, Grimm C. Polterauer S, et al. Among authors: widschwendter a. Gynecol Oncol. 2022 Apr;165(1):23-29. doi: 10.1016/j.ygyno.2022.01.033. Epub 2022 Feb 15. Gynecol Oncol. 2022. PMID: 35177279 Free article. Clinical Trial.
Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.
Trutnovsky G, Reich O, Joura EA, Holter M, Ciresa-König A, Widschwendter A, Schauer C, Bogner G, Jan Z, Boandl A, Kalteis MS, Regauer S, Tamussino K. Trutnovsky G, et al. Among authors: widschwendter a. Lancet. 2022 May 7;399(10337):1790-1798. doi: 10.1016/S0140-6736(22)00469-X. Epub 2022 Apr 25. Lancet. 2022. PMID: 35483400 Clinical Trial.
HE4 is an independent prognostic marker in endometrial cancer patients.
Mutz-Dehbalaie I, Egle D, Fessler S, Hubalek M, Fiegl H, Marth C, Widschwendter A. Mutz-Dehbalaie I, et al. Among authors: widschwendter a. Gynecol Oncol. 2012 Aug;126(2):186-91. doi: 10.1016/j.ygyno.2012.04.022. Epub 2012 Apr 21. Gynecol Oncol. 2012. PMID: 22525819
39 results